Leveragen

Leveragen is a Boston-based biotechnology company advancing antibody discovery through its proprietary Singularity Suite and Universality Suite of genetically engineered mouse models. These platforms generate either fully human single-domain antibodies or common light-chain antibodies with broad epitope coverage and natural in-vivo maturation, enabling the production of diverse, high-quality binders. By integrating advanced immunization strategies with phage display and NGS-guided expansion workflows, Leveragen accelerates the discovery of versatile antibody panels for therapeutic and diagnostic applications across modalities such as bispecifics, ADCs, mRNA, and cell therapies.